FOLH1 and Alzheimer disease: Importantly, pS2808RyR2 is also evident in AD brain (Lacampagne et al., 2017), as well as in the brains of patients who died from COVID-19, who also show reduced PDE4 and increased GCPII, PKA signaling and hyperphosphorylation of tau (Reiken et al., 2022).